Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo

Y Zhong, K Goltsche, L Cheng, F Xie, F Meng, C Deng… - Biomaterials, 2016 - Elsevier
The therapeutic efficacy of nanoscale anticancer drug delivery systems is severely truncated
by their low tumor-targetability and inefficient drug release at the target site. Here, we report …

Development of a hyaluronic acid-based nanocarrier incorporating doxorubicin and cisplatin as a pH-sensitive and CD44-targeted anti-breast cancer drug delivery …

T Yu, Y Li, X Gu, Q Li - Frontiers in Pharmacology, 2020 - frontiersin.org
Tumor-targeting nanomaterial-based chemotherapeutic drug delivery systems have been
shown to represent an efficacious approach for the treatment of cancer because of their …

Dual-responsive nanoparticles based on chitosan for enhanced breast cancer therapy

X Zhang, S Niu, GR Williams, J Wu, X Chen… - Carbohydrate …, 2019 - Elsevier
In this study, we report a novel pH and temperature responsive paclitaxel-loaded drug
delivery system based on chitosan and di (ethylene glycol) methyl ether methacrylate. This …

Construction of a tumor microenvironment pH-responsive cleavable PEGylated hyaluronic acid nano-drug delivery system for colorectal cancer treatment

X Zhang, M Zhao, N Cao, W Qin, M Zhao, J Wu… - Biomaterials …, 2020 - pubs.rsc.org
In order to improve active tumor targeting, tumor cell uptake efficiency and circulation time of
doxorubicin (DOX) in vivo, we constructed a cleavable PEGylated hyaluronic acid nano-drug …

Hyaluronic acid-based nanogel–drug conjugates with enhanced anticancer activity designed for the targeting of CD44-positive and drug-resistant tumors

X Wei, TH Senanayake, G Warren… - Bioconjugate …, 2013 - ACS Publications
Many drug-resistant tumors and cancer stem cells (CSC) express elevated levels of CD44
receptor, a cellular glycoprotein binding hyaluronic acid (HA). Here, we report the synthesis …

Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts

Y Zhong, J Zhang, R Cheng, C Deng, F Meng… - Journal of controlled …, 2015 - Elsevier
The existence of drug resistance poses a major obstacle for the treatment of various
malignant human cancers. Here, we report on reduction-sensitive reversibly crosslinked …

Fabrication of hyaluronic acid-based micelles with glutathione-responsiveness for targeted anticancer drug delivery

K Yan, Y Feng, K Gao, X Shi, X Zhao - Journal of Colloid and Interface …, 2022 - Elsevier
Hyaluronic acid (HA), a natural polymer, has gained much attention recently because of its
good biocompatibility and extensive availability. Herein, a novel drug delivery system based …

Hyaluronan-based nanocarriers with CD44-overexpressed cancer cell targeting

S Song, H Qi, J Xu, P Guo, F Chen, F Li, X Yang… - Pharmaceutical …, 2014 - Springer
Purpose The objective of the work was to evaluate the potential of hyaluronan-based
nanoparticles as tumor-targeting nano-systems for CD44-overexpressed cancer therapy …

cRGD-functionalized reduction-sensitive shell-sheddable biodegradable micelles mediate enhanced doxorubicin delivery to human glioma xenografts in vivo

Y Zhu, J Zhang, F Meng, C Deng, R Cheng… - Journal of controlled …, 2016 - Elsevier
Biodegradable micelles are one of the most studied systems for the delivery of hydrophobic
anticancer drugs. Their therapeutic efficacy in vivo is, however, suboptimal, partly due to …

Hyaluronic acid− paclitaxel conjugate micelles: Synthesis, characterization, and antitumor activity

H Lee, K Lee, TG Park - Bioconjugate chemistry, 2008 - ACS Publications
Chemical conjugates of paclitaxel and hyaluronic acid (HA) were synthesized by utilizing a
novel HA solubilization method in a single organic phase. Hydrophilic HA was completely …